Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Award

Researcher John Craig Venter Is Awarded the 2020 Edogawa-NICHE Prize for His Accomplishment in Human Genome Research


The Edogawa NICHE Prize for the year 2020 has been awarded to Dr. John Craig Venter for his contribution to research and development pertaining to the Human genome. This honor reflects Dr. Venter's lifetime accomplishments in the power of the genomics and specifically in the identification of the human genome which has radically transformed healthcare according to Prof. Gary Levy, chair, Edogawa NICHE awards committee (www.edogawanicheprize.org).

Edogawa NICHE Prize was Instituted in 2018, by the Jinseisha trust, and the Nichi-In Centre for Regenerative Medicine (NCRM), which honours scientists or clinicians whose contributions lead to the development of prevention, diagnosis or treatment of any disease, through an inter-disciplinary approach. Alumni of the Fujio Cup Quiz, a part of NCRM NICHE, (www.ncrmniche.org), have priority for nomination, a unique feature of this prize. Previous awardees include Prof James Till, University of Toronto, Canada for discovery of stem cells (2018) and Dr. Steven Rosenberg, National Institutes of Health, USA for his groundbreaking work on T-lymphocyte immunotherapy (2019).

Dr. Venter was born in Salt Lake City Utah on October 14, 1946. He started his college education at the College of San Mateo, CA and later studied Biochemistry in University of California, San Diego under biochemist Nathan O. Kaplan. After obtaining a PhD in Physiology and Pharmacology from UCSD, he became a Professor at the State University of New York and joined the National Institute of Health in 1984. He has founded Celera Genomics, The Institute of Genomic Research (TIGR), J.Craig Venter Institute (JCVI) and co-founded Human Longevity Inc and Synthetic Genomics.

His path breaking sequencing of the first human genome with the Human Genome Project further progressed to transfecting a cell with a synthetic chromosome, a feat that has opened up opportunities to develop novel solutions not only in healthcare, but also in environmental issues and energy domain.

The awarding of the Edogawa NICHE prize to Dr Venter is the most recent in a string of honors including United States Medal of Science (2008), Gardner Foundation International Award (2002), Paul Erlich and Ludwig Darmstaedter Prize (2001) and the King Faisal International Award of Science (2001). He was listed on Time Magazine's list of the most influential people in the world.

The award ceremony date will be announced later.


These press releases may also interest you

at 06:05
FreeCast, Inc. (the "Company," symbol: CAST), today announced that it has engaged Maxim Group LLC to act as the Company's exclusive financial advisor for its proposed Nasdaq Direct Listing. FreeCast is an advanced integrated hyper-targeted...

at 06:03
Arcee.ai, the industry leader in specialized language models for enterprise generative AI, is hosting a Model Merging Hackathon?offering cash prizes to developers who create the most innovative projects with Arcee.ai's open source tool MergeKit....

at 06:00
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 06:00
The latest version 9 ezCheckPrinting software from Halfpricesoft.com is a favorite among clients that need to process blank checks or draft checks for business purposes. By utilizing the features included at no additional cost customers can...

at 06:00
Uxin Limited ("Uxin" or the "Company") , China's leading used car retailer, today announced that it will release its unaudited financial results for the third quarter of fiscal year 2024 ended December 31, 2023, before the U.S. market opens on April...

at 06:00
Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) , a leading global solar project developer, owner, and operator, today announced that on April 17, 2024, it received a notice from the New York Stock Exchange indicating non-compliance...



News published on and distributed by: